Introduction
============

Nosocomial diarrhoea (ND) in children is associated with increased morbidity, mortality and length and cost of hospital stay.[@b1] Low adherence to hand washing facilitates person to person spread of diarrhoea pathogens in hospital settings, but indirect transmission also plays a role. Potential sources of transmission include water, food or contaminated surfaces such as toys or bed linen, as well as bottle and pacifier teats.[@b2] Despite controversy surrounding the recommendation of pacifier use, their use is very common in paediatric wards.[@b3] Previous reports have investigated pacifier use and the risk of diarrhoea in community settings,[@b4] but we could find no well-designed studies looking into pacifier use and hospital-acquired diarrhoea. This report investigates the association of pacifier use and the risk of ND in a cohort of children from Recife, Brazil.

Methods
=======

This was a hospital-based prospective cohort study of children aged \>28 days and \<2 years old who were admitted to the Instituto de Medicina Integral Prof. Fernando Figueira (IMIP) in Recife, Northeast Brazil. IMIP is a publically funded teaching hospital that has three paediatric wards for children \<2 years old. Each ward has an area of 25 m^2^ within which nine cradles and nine chairs (for accompanying parents). In each ward, there is a sink with constantly supplied running chlorinated water, liquid soap and disposable paper towels. For the healthcare workers, disposable latex gloves are used for patient handling during procedures when there is risk of exposure to body fluids. Children admitted to hospital for causes other than diarrhoea were consecutively enrolled between April and October 2009.

Accompanying parents or guardians were asked if pacifiers were brought to hospital and children were observed daily. The use of any pacifier during the hospital stay was the main exposure measure, while the first episode of ND was the main outcome measure. Children presenting---diarrhoea after \<72 h or who were hospitalised for \<24 h, those admitted for community-acquired diarrhoea and those presenting with haemodynamic or respiratory instability were excluded.

ND was defined as liquid stools for more than 12 h, with or without fever or vomiting, and no likely non-infectious cause that was acquired after 72 h of admission.[@b1]

The possible factors associated with nosocomial infectious diarrhoea were as follows: socioeconomic variables (per capita income of family, mother\'s level of education), sex and age (≤6 months), nutritional status (considering ≤−2 weight/age z-score WHO curve 2007),[@b5] low weight at birth (\<2500 g), prematurity (\<37 weeks gestational age), breast feeding, finger sucking habit, use of baby bottles and rotavirus vaccination status (Rotarix ® GlaxoSmithKlineBiologicals Laboratory, oral vaccine, attenuated monovalent (G1P\[8\], strain RIX4414)). Other exposure factors investigated during hospitalisation and before the occurrence of the outcome or discharge were use of medication (antibiotics, antiemetics, glucocorticoids, sedatives/analgesics, H2 blockers), fasting (feeding withdrawn due to gastric residues) and use of common invasive procedures (central venous catheter, urinary catheter, gastric tube, oxygen therapy by nasal catheter). The length of stay (LOS) and the patient-days of use of medication or devices were measured up to the occurrence of first-onset episode of diarrhoea, discharge from hospital or death.

Data from the medical and nursing charts and those from direct observation were recorded in a standardised form by a research nurse and research assistant on a daily basis until discharge. Changes in exposure factors, clinical condition or diarrhoeal episodes were recorded.

A sample size calculation was performed using EpiInfo V.3.5.1. To inform power calculations, we did use local ward survey data that found that a third of the mothers of babies hospitalised in the weeks prior to study enrolment reported pacifier use. Assuming a 9% frequency of ND in non-exposed children, 354 children would be required to detect a difference of 20% in the risk of diarrhoea, with 80% statistical power and a 5% level of significance. To allow for possible losses, 378 children were enrolled.

Data were entered in duplicate, and statistical analyses were performed using STATA V.9.1. ORs were described with 95% CIs and each variable was controlled for LOS. Use of pacifiers and variables associated with the risk of diarrhoea at a level of p\<0.2 in bivariate analysis were selected for inclusion in the multivariate model. A backward stepwise procedure was followed to obtain adjusted OR in multivariate logistical regression. The R software V.2.6.0 was used for survival analysis (The R Foundation for Statistical Computing).

To assess colonisation by faecal coliforms, pacifier teats were immersed in brain--heart-infusion media. Specimens were immediately taken to the hospital microbiology laboratory and plated on to MacConkey and Hektoen Enteric Agar (Himedia Laboratories, Mumbai, India). Isolates with appropriate colonial morphology were subcultured and confirmed to be oxidase-negative Gram-negative bacilli. TSI (Triple Sugar Iron Agar) and SIM (Sulfide Indole Motility) tests were used to differentiate *Klebsiella spp.* from other enteric bacilli according to the Clinical and Laboratory Standards Institute guidelines.[@b6]

The study was approved by IMIP\'s Research Ethics Committee and all parents or guardians had signed a consent form.

Results
=======

Throughout the study period, 378 of 536 infants fulfilled the eligibility criteria. Fifty-six (10.4%) children with community-acquired diarrhoea, 90 with either respiratory or haemodynamic instability; five who stayed in hospital for \<24 h were excluded. There were seven losses (1.3%) due to failure to obtain informed consent.

The cohort of 378 infants was followed for a total of 2932 patient-days. There was a predominance of male (59%), and the median age was 4.1 months (IQR 2--9.6 months). Children came from a low socioeconomic status with median family income (monthly) per capita of U\$64.87 (IQR 32.49--93.23) and maternal schooling of 9 years (IQR 7--12 years) among those with ND and 8 years for those without diarrhoea (IQR 6--12 years). Fifty-five per cent (208/378) of children were being breast fed (either exclusively or mixed) at the time of admission to hospital. The median duration of exclusive breast feeding was 2 months.

Thirty-three of the 378 infants developed ND (8.7%) with an incidence density of 11.3 per 1.000 patient-days. [Table 1](#tbl1){ref-type="table"} shows the distribution of infants with and without ND according to the factors reported at admission and observed during hospitalisation. Almost half of the infants (51.4%) enrolled at this cohort study (194/378) used a pacifier during their stay in hospital. The rate of pacifier use in breastfed babies was 65% (135/208) and 35% for non-breastfed babies (59/170). Pacifiers users presented 8.2% (16/194) of hospital-acquired diarrhoea compared with 9.2% (17/184) at non-users (time adjusted bivariate analysis OR=0.88, 95% CI 0.43 to 1.80). There were no differences between median LOS for pacifier users (6 days, IQR 4--10 days) and non-users (6 days, IQR 4--9 days). Twelve (3%) children died during follow-up, two of whom had ND.

###### 

Frequency distribution and bivariate analysis of the association between intrinsic and extrinsic factors and the occurrence of nosocomial diarrhoea (ND) in infants paediatric wards at IMIP, from 1 April to 31 October 2009

  Variables                                                                      All infants    Patients with ND   Patients without ND   OR (95% CI)[\*](#table-fn1){ref-type="table-fn"}   p Value
  ------------------------------------------------------------------------------ -------------- ------------------ --------------------- -------------------------------------------------- ----------
                                                                                 n (%)          n (%)              n (%)                                                                    
  Intrinsic factors                                                                                                                                                                         
   Pacifier user in the hospital                                                 194 (51.3)     16 (48.5)          178 (51.6)            0.88 (0.43 to 1.80)                                0.72
   Bottle feeding                                                                281 (74.3)     21 (64.0)          260 (75.4)            0.57 (0.27 to 1.21)                                **0.15**
   Finger sucking habit                                                          36 (9.5)       3 (9.0)            33 (9.6)              0.95 (0.27 to 1.32)                                0.94
   Rotavirus vaccination                                                         173 (45.8)     16 (48.5)          157 (45.5)            0.87 (0.43 to 1.80)                                0.73
   Age ≤6 months                                                                 234 (62.0)     21 (64.0)          213 (61.7)            1.09 (0.52 to 2.29)                                0.82
   Sex, male                                                                     223 (59.0)     21 (64.0)          202 (58.5)            1.25 (0.59 to 2.62)                                0.56
   Low weight at birth                                                           61 (16.1)      5 (15.1)           56 (16.2)             0.92 (0.34 to 2.48)                                0.87
   Prematurity                                                                   67 (17.7)      6 (18.2)           61 (17.7)             1.03 (0.41 to 2.61                                 0.94
   Breast feeding                                                                208 (55.0)     12 (36.4)          196 (56.8)            0.43 (0.20 to 0.90)                                **0.03**
   Nutritional status, weight/age z-score ≤−2                                    56 (14.8)      6 (18.2)           50 (14.5)             1.3 (0.50 to 3.34)                                 0.59
  Extrinsic factors                                                                                                                                                                         
   Use of devices or medication                                                                                                                                                             
    Central venous catheter                                                      31 (8.2)       6 (18.2)           25 (7.2)              2.96 (1.06 to 8.23)                                **0.04**
    Peripheral venous catheter                                                   281 (74.3)     25 (75.8)          256 (74.2)            1.08 (0.47 to 2.49)                                0.85
    Gastric tube                                                                 86 (22.7)      12 (36.4)          74 (21.4)             2.1 (0.986 to 4.53)                                **0.06**
    Oxygen therapy by nasal catheter                                             48 (12.7)      6 (18.2)           42 (12.2)             1.59 (0.62 to 4.13)                                0.34
    Antibiotic                                                                   264 (69.8)     25 (75.8)          239 (69.3)            1.38 (0.60 to 3.16)                                0.44
    Corticoids                                                                   113 (29.9)     11 (33.3)          102 (29.7)            1.19 (0.55 to 2.54)                                0.66
    Gastric acid H2 blockers                                                     54 (14.2)      6 (18.2)           48 (14.0)             1.36 (0.53 to 3.52)                                0.52
    Prolonged fasting                                                            73 (19.3)      6 (18.2)           67 (19.4)             0.91 (0.36 to 2.30)                                0.84
                                                                                 Median (IQR)   Median (IQR)       Median (IQR)                                                             
   LOS, patient-days[†](#table-fn2){ref-type="table-fn"}                         266 (4--10)    6 (4--10)          6 (4--9)              1.00 (0.97 to 1.04)                                0.83
   Device utilisation, patient-days of use[†](#table-fn2){ref-type="table-fn"}                                                                                                              
    Central venous catheter                                                      177 (0--0)     0 (0--0)           0 (0--0)              1.09 (0.97 to 1.23)                                **0.14**
    Peripheral venous catheter                                                   856 (0--3)     2 (1--3)           2 (0--3)              0.98 (0.84 to 1.13)                                0.76
    Gastric tube                                                                 465 (0--0)     0 (0--2)           0 (0--0)              1.10 (0.98 to 1.22)                                **0.09**
    Oxygen therapy by nasal catheter                                             125 (0--0)     0 (0--0)           0 (0--0)              1.32 (1.04 to 1.68)                                **0.02**
    Antibiotic                                                                   1449 (0--6)    7 (1--11)          2 (0--6)              1.49 (1.28 to 1.74)                                **0.00**
    Corticoids                                                                   408 (0--1)     0 (0--1)           0 (0--1)              1.04 (0.92 to 1.18)                                0.50
    Gastric acid H2 blockers                                                     344 (0--0)     0 (0--0)           0 (0--0)              1.03 (0.93 to 1.13)                                0.61
    Prolonged fasting                                                            145 (0--0)     0 (0--0)           0 (0--0)              0.95 (0.71 to 1.28)                                0.75

OR adjusted for LOS to until first-onset episode of diarrhoea, discharge or death. p values of less than 0.2 are shown in bold numbers.

Patient-days until first-onset episode of ND, discharge or death.

IMIP, Instituto de Medicina Integral Prof. Fernando Figueira; LOS, length of stay.

In multivariate logistic regression analysis ([table 2](#tbl2){ref-type="table"}), risk and protective factors for nosocomial diarrhoea, controlled for LOS, were duration of oxygen by nasal catheter use (OR=1.61, 95% CI 1.18 to 2.20), days of antimicrobial use (OR=1.62, 95% CI 1.34 to 1.94), being breast fed during the hospitalisation (OR=0.40, 95% CI 0.17 to 0.93), each day on hospital stay (OR=0.65, 95% CI 0.53 to 0.80) and pacifier user (OR=1.03, 95% CI 0.43 to 2.47).

###### 

Multivariate analysis of the risk factors for occurrence of ND in IMIP paediatric ward, from 1 April to 31 October 2009

  Variables                                                     OR (95% CI)           p Value
  ------------------------------------------------------------- --------------------- ---------
  Days of use of oxygen therapy (nasal catheter)                1.61 (1.18 to 2.20)   0.003
  Days of use of antibiotics                                    1.62 (1.34 to 1.94)   0.000
  Breast feeding                                                0.40 (0.17 to 0.93)   0.034
  LOS in paediatric ward[\*](#table-fn3){ref-type="table-fn"}   0.65 (0.53 to 0.80)   0.000
  Pacifier user                                                 1.03 (0.43 to 2.47)   0.936

OR controlled by LOS until onset of ND, discharge or death.

IMIP, Instituto de Medicina Integral Prof. Fernando Figueira; ND, nosocomial diarrhoea; LOS, length of stay.

The likelihood of a child remaining free of ND for each day of stay in the paediatric ward was estimated using the Kaplan--Meier method, and the curves for pacifier users and non-users were drawn ([figure 1](#fig1){ref-type="fig"}). The probability of a child remaining free of an episode of diarrhoea up to the seventh day of hospitalisation in the ward was 91.2% (95% CI 87.7% to 94.9%). The log-rank test showed no statistical difference between pacifier users and non-users.

![Stratified curve of time until occurrence of diarrhoea for the non-pacifier and pacifier users.](bmjopen-2011-000427fig1){#fig1}

One hundred and sixty-nine (87.1%) of 194 pacifiers were available for culture, 16 belonged to the infants with diarrhoea and 153 for those without diarrhoea. Faecal coliforms were isolated in 16% (27/169) of samples. Among the infants with diarrhoea, in only one pacifier was isolated a coliform (6.3%) and 16.0% within those without diarrhoea (p=0.47).

Discussion
==========

Despite the high costs and morbidity associated with ND, the frequent use of pacifiers by children admitted to hospital and the potential of enteropathogens colonising pacifiers, this is, to our knowledge, the first report to prospectively assess the role of pacifiers in ND. The risk of ND in children between 29 days and \<2 years of age at IMIP paediatric wards during the 6-month study period was not different in children who were classified as pacifier users versus children who did not use a pacifier.

Most infants in our cohort were pacifier user; however, there was no statistically significant association between pacifier use and the occurrence of nosocomial diarrhoea. Described by the terms 'pacifier', and regionally in northeastern Brazil as 'comfort', the use of pacifiers seems to be indicated in order to 'pacify' or 'comfort' the restless, especially suffering ill child.[@b7] [@b8] Randomised clinical study investigated the effect of non-nutritive sucking (sucking of sterile water, sucrose or pacifier) as an analgesic during invasive procedures and has been shown that the use of a pacifier calms and modifies pain perception.[@b9]

The lack of an association between pacifier use and diarrhoea has been previously reported in a community setting. Tomasi *et al*[@b4] performed a cross-sectional study in poor neighbourhoods of Pelotas, Brazil, and found no association between pacifier use and community-acquired diarrhoea, even though faecal coliforms were present in half of the tested pacifiers. The authors suggested that, in the highly contaminated environments where families from low socioeconomic backgrounds live, the added risk of using pacifiers would not significantly change the incidence of diarrhoea. This may also be true for the baby cradle environment in a busy and crowded hospital ward, where contamination vectors are likely to include the hands of professionals and associates, as well as food, water, utensils and hospital supplies.[@b2] [@b4]

The protective effect of breast feeding in ND, observed in this study (OR=0.40, 95% CI 0.17 to 0.93, p=0.03), corroborates the evidence from the literature on the protection of breast feeding in prevention of infections especially diarrhoeal diseases in the community.[@b10; @b11; @b12] The ND was an adverse event that occurred in the first days of hospitalisation.

Arguably, the relative importance of contaminated pacifiers could be different in settings with lower incidences of nosocomial gastrointestinal infection. Accompanying persons stay with their children for most of the time and it is not culturally acceptable to offer a child someone else\'s pacifier, we deem as small the risk of an occasional unrecorded exposure. However, circumstances similar to the present study site are often found in many settings in low- and middle-income countries, where the burden of diarrhoea is highest. The present study suggests that, in isolation, measures to restrict the use of pacifiers in hospital are unlikely to affect the incidence of ND in such settings. Health professionals should thus focus on known effective measures, such as hand washing, and look for factors other than the use of pacifiers in their efforts to prevent spread of diarrhoeal pathogens in the hospital.[@b2] [@b13] [@b14]

While the evidence-based benefits and risks of pacifiers should inform the policies of healthcare facilities as highlighted by the Unicef/WHO Baby-Friendly Hospital Initiative, it should be remembered that there are still controversial[@b3] [@b15] potentially adverse effects arising from the use of pacifiers in early weaning of breastfeeding infants.
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